Complications of transpyloric nutrition in children.

1Paediatric Intensive Care, Royal Brompton Hospital, London, UK.
European journal of clinical nutrition (Impact Factor: 2.71). 03/2009; 63(7):919; author reply 920. DOI: 10.1038/ejcn.2009.3
Source: PubMed
5 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To study the risk factors for gastrointestinal complications related to enteral nutrition in critically ill children. A prospective, observational study. Pediatric intensive care unit. Five hundred and twenty-six critically ill children who received transpyloric enteral nutrition(TEN). Univariate and multivariate logistic regression analysis were used to identify risk factors for gastrointestinal complications. Sixty six patients (11.5%) presented gastrointestinal complications, 33 (6.2%) abdominal distension and/or excessive gastric residue, 34 (6.4%) diarrhea, one gastrointestinal bleeding, three necrotizing enterocolitis and one duodenal perforation. Enteral nutrition was definitively suspended because of gastrointestinal complications in 11 (2.1%) patients. Fifty patients (9.5%) died. Gastrointestinal complications were more frequent in the patients who died. Death was related to complications of the nutrition in only one patient. The frequency of gastrointestinal complications was significantly higher in children with shock, acute renal failure, hypokalemia, hypophosphatemia and in those receiving dopamine, epinephrine and vecuronium. The stepwise multivariate logistic regression analysis showed that the most important factors associated with gastrointestinal complications were shock, epinephrine at a rate higher than 0.3 microg/kg/min and hypophosphatemia. The tolerance of TEN in critically ill children is good, although the incidence of gastrointestinal complications is higher in patients with shock, acute renal failure, hypokalemia, hypophosphatemia, and those receiving epinephrine, dopamine, and vecuronium.
    European Journal of Clinical Nutrition 04/2008; 62(3):395-400. DOI:10.1038/sj.ejcn.1602710 · 2.71 Impact Factor


5 Reads
Available from